-
The 6, 000-patient study was designed to show that AtheroGenics' drug, known by the code name AGI-1067, decreased the risk not only of heart attack, stroke and death but also of less important heart problems, including stent procedures, bypass surgery and chest pain.
FORBES: Magazine Article
-
Lilly's own studies show that Zyprexa doubles the risk of stroke death when given to elderly dementia patients.
FORBES: Lilly's Big Fat Risk
-
Moreover, there are additional factors buttressing a need for caution: Two retrospective analyses of Medicare claims both found increased risks of stroke and death among patients using Avastin for wet AMD over Lucentis.
FORBES: Blinded By Savings? Is Cost Trumping Risk On Blindness Drug?